Fibrillogenesis of Alzheimer Aβ peptides studied by fluorescence energy transfer

Journal of Molecular Biology

Volumn 269, Issue 2, 1997, Pages 214-224

  Huang, T H Jackson ^a   Fraser, Paul E ^a,b   Chakrabartty, Avijit ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer's disease; Amyloid; Fibril; Fluorescence energy transfer; Spectroscopy

Indexed keywords

AMYLOID BETA PROTEIN; MONOMER; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ENERGY TRANSFER; FIBER; FLUORESCENCE ANALYSIS; KINETICS; PRIORITY JOURNAL; PROTEIN POLYMERIZATION; AMINO ACID SEQUENCE; CHEMICAL MODEL; CHEMISTRY; DRUG DESIGN; DRUG SCREENING; METHODOLOGY; MOLECULAR GENETICS; PH; REPRODUCIBILITY; SPECTROFLUOROMETRY;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; ENERGY TRANSFER; HYDROGEN-ION CONCENTRATION; MODELS, CHEMICAL; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE;

EID: 0031555940     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1997.1050     Document Type: Article

References (28)

1. Barrow C. J., Zagorski M. G. Solution structures of β-peptide and its constituent fragments: relation to amyloid deposition. Science. 253:1991;179-182.
2. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C., Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 267:1992;546-554.
3. Edelhoch H. Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry. 6:1967;1948-1954.
4. Fairclough R. H., Cantor C. R. The use of singlet-singlet energy transfer to study macromolecular assemblies. Methods Enzymol. 48:1978;347-379.
5. Fersht A. Enzyme Structure and Mechanism. 1977;Freeman and Company Limited, Reading.
6. Fraser P. E., Nguyen J. T., Surewicz W. K., Kirschner D. A. pH-dependent structural transitions of Alzheimer amyloid β/A4 peptides. Biophys. J. 60:1991;1190-1201.
7. Fraser P. E., Nguyen J. T., Inouye H., Surewicz W. K., Selkoe D. J., Podlisny M. B., Kirschner D. A. Fibril formation by primate, rodent, and Dutch-hemorrahagic analogues of Alzheimer amyloid β-protein. Biochemistry. 31:1992;10716-10723.
8. Fraser P. E., McLachlan D. R., Surewicz W. K., Mizzen C. A., Snow A. D., Nguyen J. T., Kirschner D. A. Conformation and fibrillogenesis of Alzheimer Aβ peptides with selected substitutions of charged residues. J. Mol. Biol. 244:1994;64-73.
9. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 373:1995;523-527.
10. Ghelis C., Yon J. Protein Folding. 1982;Academic Press, New York.
11. Goate A., Chartier-Harlin M. C., Mullan M., Brown J., Crawford F., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
12. Halverson K., Fraser P. E., Kirschner D. A., Lansbury P. T. Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic beta-protein fragments. Biochemistry. 29:1990;2639-2644.
13. Hilbich C., Kister-Wolke B., Reed J., Masters C. L., Beyreuther K. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease βA4 peptides. J. Mol. Biol. 228:1992;460-473.
14. Hudson E. N., Weber G. Synthesis and characterization of two fluorescent sulfhydryl reagents. Biochemistry. 12:1973;4154-4161.
15. Kirschner D. A., Inouye H., Duffy L. K., Sinclair A., Lind M., Selkoe D. J. Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrilsin vitro. Proc. Natl Acad. Sci. USA. 84:1987;6953-6957.
16. 1. Biochemistry. 34:1995;5191-5200.
17. Muller-Hill B., Beyreuther K. Molecular biology of Alzheimer's disease. Annu. Rev. Biochem. 58:1989;287-307.
18. Murrell J., Farlow M., Ghetti B., Benson M. D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science. 254:1991;97-99.
19. Netter H. Theoretical Biochemistry. 1969;Oliver and Boyd, Edinburgh.
20. Oosawa F., Kasai M. A theory of linear and helical aggregations of macromolecules. J. Mol. Biol. 4:1962;10-21.
21. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., Cotman C. W. Neurodegeneration induced by beta-amyloid peptidesin vitro. J. Neurosci. 13:1993;1676-1687.
22. Selkoe D. J. Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurochem. Sci. 16:1993;403-409.
23. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Sinha S., Schlossmacher M. G., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D. J., Lieberburg I., Schenk D. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature. 359:1992;325-327.
24. Stryer L. Fluorescence energy transfer as a spectroscopic ruler. Annu. Rev. Biochem. 47:1978;819-846.
25. Taylor D. L., Reidler J., Spudich J. A., Stryer L. Detection of actin assembly by fluorescence energy transfer. J. Cell Biol. 89:1981;362-367.
26. Terzi E., Holzemann G., Seelig J. Reversible random coil - β-sheet transition of the Alzheimer β-amyloid fragment (25-35). Biochemistry. 33:1994;1345-1350.
27. Wood S. J., Wetzel R., Martin J. D., Hurle M. R. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4. Biochemistry. 34:1995;724-730.
28. Yankner B. A., Dawes L. R., Fisher S., et al. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 245:1989;417-420.